TY  - GEN
AU  - Zhong,Zhixiong
AU  - Hou,Jingyuan
AU  - Zhang,Qifeng
AU  - Li,Bin
AU  - Li,Cunren
AU  - Liu,Zhidong
AU  - Yang,Min
AU  - Zhong,Wei
AU  - He,Xuebo
AU  - Wu,Hesen
AU  - Zhong,Miaocai
AU  - Zhao,Pingsen
TI  - Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China
SN  - 1432-1041
PY  - 2018///0904
KW  - Acute Coronary Syndrome
KW  - diagnostic imaging
KW  - Adenosine
KW  - analogs & derivatives
KW  - Aged
KW  - Asian People
KW  - genetics
KW  - Chi-Square Distribution
KW  - China
KW  - Clinical Decision-Making
KW  - Clopidogrel
KW  - Cytochrome P-450 CYP2C19
KW  - Drug-Eluting Stents
KW  - Female
KW  - Gene Frequency
KW  - Genetic Predisposition to Disease
KW  - Hemorrhage
KW  - chemically induced
KW  - Heterozygote
KW  - Homozygote
KW  - Humans
KW  - Hypertension
KW  - complications
KW  - Kaplan-Meier Estimate
KW  - Logistic Models
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - blood
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Pharmacogenetics
KW  - Pharmacogenomic Variants
KW  - Phenotype
KW  - Platelet Aggregation Inhibitors
KW  - Polymorphism, Genetic
KW  - Precision Medicine
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Stroke
KW  - Ticagrelor
KW  - Ticlopidine
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1007/s00228-017-2393-1
ER  -